
Eli Lilly and Company, Crinetics Pharmaceuticals, and Johnson & Johnson are the three Medical stocks to watch today, according to MarketBeat’s stock screener tool. Medical stocks are shares of companies in the healthcare industry that investors can buy and sell on the stock market. They include businesses involved in pharmaceuticals, medical devices, biotechnology, hospitals, and other healthcare services, and are often followed by investors looking for growth or stability tied to demand for health-related products and care. These companies had the highest dollar trading volume of any Medical stocks within the last several days.
Eli Lilly and Company (LLY)
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.
Crinetics Pharmaceuticals (CRNX)
Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company's lead product candidate is paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist, which is in Phase 3 trial for the treatment of acromegaly; and Phase 2 trial for treating carcinoid syndrome associated with neuroendocrine tumors.
Read Our Latest Research Report on CRNX
Johnson & Johnson (JNJ)
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.
Read Our Latest Research Report on JNJ
Read More
- MarketBeat’s Top Five Stocks to Own in July 2026
- The Market Just Got Shaken—These 3 ETFs May Come Out Stronger
- Meta Platforms’ Cloud Push: Growth Opportunity Versus AI Concerns
- Why Penguin Solutions May Be the Smartest AI Infrastructure Stock
- Want Anthropic Exposure Before the IPO? These 2 AI Giants Are Already There
- 3 Beaten-Down Trades That Could Pay Off in a Market Correction
